PURPOSE OF TEST
The HEMOCHRON Signature Elite, ACT-LR is a quantitative assay for monitoring heparin anticoagulation during various medical procedures. The ACT-LR demonstrates linear correlation to the anticoagulation effects of heparin up to 2.5 units / ml of blood. It is intended for use in monitoring low to moderate heparin doses frequently employed in procedures such as cardiac catheterization, extracorporeal membrane oxygenation (ECMO), hemodialysis, and Percutaneous Transluminal Coronary Angioplasty (PTCA). The ACT-LR test is for in vitro diagnostic use and is for use with any model HEMOCHRON Whole Blood Microcoagulation System.
IDA Pages (Clinical Indications, Documentation Plan, Clinical Actions)
INITIAL ORIENTATION, TRAINING & COMPETENCY
Initial Orientation & Training – This must be completed (once) with all new staff trained to use this test.
6 Methods of Competency – This must be completed by all testing personnel 1) 6 months after inital training; and 2) annually thereafter.
For technical issues, contact Tech Support @ 732.548.5700
MATERIAL SAFETY DATA SHEETS (MSDS)